Putative mechanism for cancer suppression by PLGA nanoparticles loaded with Peganum harmala smoke extract

References

• Abbott, L.B., Bettmann, G.T., and Sterling, T.M., 2008. Physiology and recovery of African rue (Peganum harmala) seedlings under water-deficit stress. Weed science, 56 (1), 52–57.
   Web of Science ®Google Scholar
• Aslam, M.S., et al., 2014. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. Journal of cancer therapy, 5 (8), 817–822.
   Google Scholar
• Atrooz, O.M., et al., 2018. Antiproliferative, antioxidant, and antibacterial activities of crude plant extracts of Asphodeline lutea L. and Peganum harmala L. World journal of pharmaceutical research, 7 (11), 148–167.
   Google Scholar
• Baban, D.F. and Seymour, L.W., 1998. Control of tumour vascular permeability. Advanced drug delivery reviews, 34 (1), 109–119.
   PubMed Web of Science ®Google Scholar
• Benzie, I.F. and Strain, J.J., 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical biochemistry, 239 (1), 70–76.
   PubMed Web of Science ®Google Scholar
• Berrougui, H., et al., 2006. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed's in isolated rat aorta. Pharmacological research, 54 (2), 150–157.
   PubMed Web of Science ®Google Scholar
• Bishayee, A. and Sethi, G., 2016. Bioactive natural products in cancer prevention and therapy: progress and promise. Seminars in cancer biology, 40–41, 1–3.
   PubMed Web of Science ®Google Scholar
• Bouzenna, H., et al., 2017. Potential protective effects of alpha-pinene against cytotoxicity caused by aspirin in the IEC-6 cells. Biomedicine & pharmacotherapy, 93, 961–968.
   PubMed Web of Science ®Google Scholar
• Cragg, G.M. and Newman, D.J., 2005. Plants as a source of anti-cancer agents. Journal of ethnopharmacology, 100 (1–2), 72–79.
   PubMed Web of Science ®Google Scholar
• Danhier, F., et al., 2012. PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161 (2), 505–522.
   PubMed Web of Science ®Google Scholar
• Esmaeili, M.H., Haghdost, H., and Gheybea, N., 2007. Effects of opiate receptor agonists and antagonists on spontaneous seizure activity in hippocampal slices. Koomesh, 9 (1), 27–32.
   Google Scholar
• Faridi, P., Ghasemi, Y., and Mohagheghzadeh, A., 2013. Chemical composition of Peganum harmala smoke and volatile oil. Journal of essential oil bearing plants, 16 (4), 469–473.
   Web of Science ®Google Scholar
• Garinot, M., et al., 2007. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. Journal of controlled release, 120 (3), 195–204.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Burgos, E. and Gómez-Serranillos, M., 2012. Terpene compounds in nature: a review of their potential antioxidant activity. Current medicinal chemistry, 19 (31), 5319–5341.
   PubMed Web of Science ®Google Scholar
• Hafezi Ghahestani, Z., et al., 2017. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artificial cells, nanomedicine, and biotechnology, 45 (5), 955–960.
   PubMed Web of Science ®Google Scholar
• Hamsa, T.P. and Kuttan, G., 2011. Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma. Chinese medicine, 6 (1), 11–18.
   PubMed Web of Science ®Google Scholar
• Herraiz, T., et al., 2010. β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food and chemical toxicology, 48 (3), 839–845.
   PubMed Web of Science ®Google Scholar
• Hobbs, S.K., et al., 1998. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proceedings of the national academy of sciences of the United States of America, 95 (8), 4607–4612.
   PubMed Web of Science ®Google Scholar
• Kartal, M., Altun, M., and Kurucu, S., 2003. HPLC method for the analysis of harmol, harmalol, harmine and harmaline in the seeds of Peganum harmala L. Journal of pharmaceutical and biomedical analysis, 31 (2), 263–269.
   PubMed Web of Science ®Google Scholar
• Kim, C.-K. and Lim, S.-J., 2002. Recent progress in drug delivery systems for anticancer agents. Archives of pharmacal research, 25 (3), 229–239.
   PubMed Web of Science ®Google Scholar
• Lamchouri, F., 2014. Antitumor properties and toxicity effects of Peganum harmala L. (Zygophyllaceae). Plant science today, 1 (4), 192–195.
   Google Scholar
• Li, C., et al., 2019. Recent progress in drug delivery. Acta pharmaceutica sinica B, 9 (6), 1145–1162.
   PubMed Web of Science ®Google Scholar
• Lombardo, D., Kiselev, M.A., and Caccamo, M.T., 2019. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. Journal of nanomaterials, 2019, 1–26.
   Web of Science ®Google Scholar
• Maeda, H., 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advances in enzyme regulation, 41, 189–207.
   PubMedGoogle Scholar
• Marwat, S.K. and Ur Rehman, F., 2011. Medicinal and pharmacological potential of harmala (Peganum harmala L.) seeds. In: V.R. Preedy, R.R. Watson and V.B. Patel, eds. Nuts and seeds in health and disease prevention. London: Elsevier, 585–599.
   Google Scholar
• Moloudizargari, M., et al., 2013. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacognosy reviews, 7 (14), 199.
   PubMedGoogle Scholar
• Nagai, H. and Kim, Y.H., 2017. Cancer prevention from the perspective of global cancer burden patterns. Journal of thoracic disease, 9 (3), 448–451.
   PubMed Web of Science ®Google Scholar
• Parsa, N., 2012. Molecular and cellular basis of human cancer. Journal of cell & tissue, 2 (4), 365–376.
   Google Scholar
• Passos, I.D. and Mironidou-Tzouveleki, M., 2016. Hallucinogenic plants in the Mediterranean countries. In: V.R. Preedy, ed. Neuropathology of drug addictions and substance misuse. London: Elsevier, 761–772.
   Google Scholar
• Rajurkar, N.S. and Hande, S., 2011. Estimation of phytochemical content and antioxidant activity of some selected traditional Indian medicinal plants. Indian journal of pharmaceutical sciences, 73 (2), 146.
   PubMed Web of Science ®Google Scholar
• Roberto, D., et al., 2010. Antioxidant activity of limonene on normal murine lymphocytes: relation to H2O2 modulation and cell proliferation. Basic & clinical pharmacology & toxicology, 106 (1), 38–44.
   PubMed Web of Science ®Google Scholar
• Roostaee, Z., 2018. Effect of alkaloids belong to β-carbolines family in Peganum harmala on cancer cells. Sarem journal of reproductive medicine, 3 (1), 73–78.
   Google Scholar
• Sanaeimehr, Z., Javadi, I., and Namvar, F., 2018. Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction. Cancer nanotechnology, 9 (1), 3.
   PubMed Web of Science ®Google Scholar
• Seyed Hassan Tehrani, S., et al., 2014. Growth inhibitory impact of Peganum harmala L. on two breast cancer cell lines. Iranian journal of biotechnology, 12 (1), 8–14.
   Web of Science ®Google Scholar
• Shafiee, H.A. and Moravej-Salehi, E., 2015. Anbarnesa: the past tradition, the future medicine. Iranian red crescent medical journal, 17 (12), e29536.
   PubMed Web of Science ®Google Scholar
• Shah, B.B., et al., 2018. Anti‐leukemic and anti‐angiogenic effects of d‐limonene on K562‐implanted C57 BL/6 mice and the chick chorioallantoic membrane model. Animal models and experimental medicine, 1 (4), 328–333.
   PubMedGoogle Scholar
• Shahverdi, A., et al., 2008. Antimicrobial and cytotoxicity potential of Peganum harmala smoke. Pharmacognosy magazine, 4 (15), 236.
   Web of Science ®Google Scholar
• Stetefeld, J., McKenna, S.A., and Patel, T.R., 2016. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophysical reviews, 8 (4), 409–427.
   PubMedGoogle Scholar
• Teleanu, R.I., et al., 2019. Tumor angiogenesis and anti-angiogenic strategies for cancer treatment. Journal of clinical medicine, 9 (1), 84.
   PubMed Web of Science ®Google Scholar
• Yusop, A.H., et al., 2018. Structure, degradation, drug release and mechanical properties relationships of iron-based drug eluting scaffolds: the effects of PLGA. Materials & design, 160, 203–217.
   Web of Science ®Google Scholar